7:01 AM ET
8-K
Court & Legal Update
United Therapeutics Court & Legal Update
United Therapeutics entered into a comprehensive settlement agreement with Liquidia Technologies to resolve multiple patent infringement and trade secret lawsuits. Liquidia will pay United Therapeutics $330.4 million in damages and has agreed to remove the PH-ILD indication from its Yutrepia product labeling, while United Therapeutics will pay Liquidia $10.0 million to resolve separate infringement claims.
- Counterparty
- Liquidia Technologies, Inc.